Article
Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations.
Progress in neuro-psychopharmacology & biological psychiatry - 13 Jul 2021
Ma Lingyue, Xiang Qian, Zhao Nan, Hu Changqing, Fang Meng, Tan Yunlong, Chen Song, Wang Zining, Liu Pinglan, Sun Kaoxiang, Li Youxin, Wu Fuxi, Tian Hongjun, Fang Maosheng, Zhao Xia, Wang Gang, Cui Yimin
Abstract excerpt
BACKGROUND: LY03004, a novel investigational risperidone long-acting injection (LAI) microsphere formulation, can release risperidone more quickly after injection than Risperdal Consta®. This study aimed to investigate the effects of genetic polymorphisms on the pharmacokinetics of LY03004 compared with those on Risperdal Consta®. METHODS: A total of 100 Chinese patients with stable schizophrenia were randomly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
